Jun 22, 2020 / 03:30PM GMT
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Bristol Myers Squibb Early Pipeline & Immuno-Oncology Call. (Operator Instructions) Please be advised that today's conference may be recorded. (Operator Instructions)
I would now like to hand the conference over to your speaker, Tim Power. Sir, please go ahead.
Timothy Power - Bristol-Myers Squibb Company - VP & Head of IR
Thanks, Latif, and good morning, everyone. Thanks for joining us today for the first of our 3-part investor series. The plan for today is that we'll have a presentation followed by a Q&A session. And so if you're not participating via the webcast, you can always go ahead and download the materials from bms.com.
Joining me today for the presentation are Giovanni Caforio, Chairman and Chief Executive Officer; Rupert Vessey, Executive Vice President, Research and Early Development; Samit Hirawat, Chief Medical Officer, Global Drug Development; and Chris Boerner, Chief Commercialization Officer. And also with me today for the Q&A session are
Bristol-Myers Squibb Co Three-Part Investor Series: Early Pipeline and Immuno-Oncology Transcript
Jun 22, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers